How we make money
Readers should be able to tell who funds this publication and whether a commercial relationship could affect what they see. This page describes our current position and the standards for any future paid relationship.
On this page
Kaden Coziar is the responsible publisher. The site’s legal operator is Kozi Publishing LLC. Questions about funding can be sent to partners@peptidecareindex.com.
Current funding and relationships
Peptide Care Index currently earns no revenue. We have no affiliate, paid-referral, sponsorship, or advertising arrangements. No provider, pharmacy, or manufacturer pays us for the coverage on this site. Current provider links are unpaid links and do not earn us a commission.
Readers do not pay to use the publication or its guide.
This disclosure applies to Peptide Care Index. It should not be interpreted as a claim that its publisher has no commercial activity elsewhere.
How we may earn revenue later
We may establish commercial relationships to support the publication. These could include affiliate commissions, disclosed referral fees, or clearly labeled advertising and sponsorships.
With an affiliate relationship, we could earn money when a reader follows a link and completes an action specified by the partner, such as an eligible purchase. A referral arrangement could compensate us for an introduction or another agreed action. Sponsorship or advertising could pay for a labeled placement. The terms can differ between partners.
Before a paid relationship is used on the site, we update this page to identify the partner and the type of compensation. The affected page will include a clear disclosure close to the relevant comparison, placement, or link. Readers should not have to find this page to discover that an action could earn us money.
We will not describe a paid link as unpaid or assume that every reader’s price is unchanged. Where a discount or price claim is made, the page must explain the actual terms and any important qualifications.
Commercial incentives are a potential conflict
Payment creates an incentive to send readers to a paying partner. Different commissions can also create an incentive to favor one partner over another. Disclosure makes that incentive visible; it does not eliminate it.
Our editorial comparisons use the criteria stated on the page, including the available access records, evidence, costs, and provider terms. Compensation is not evidence of clinical effectiveness, approval, licensing, safety, product quality, or personal suitability. It must not be used to resolve an uncertain fact in a partner’s favor.
Readers should inspect the comparison method and original sources rather than treat a commercial relationship as a quality certificate. We include relevant unpaid options when they meet the stated scope, even when they offer no way for us to earn revenue.
Editorial coverage and sponsored placements
Providers cannot buy a favorable editorial finding or make payment a condition of correcting a verified factual error. Paid placements must be clearly identified and distinguished from comparisons produced under our methodology.
A sponsored placement is a commercial message, not a clinical endorsement. Any sponsored content must identify its sponsor and remain subject to accuracy standards. The publication remains responsible for what it chooses to publish.
Current comparison lists use alphabetical order, as described in our methodology. If a future comparison uses another order or makes a recommendation, the page will state the relevant criteria. A paid placement must not be presented as an unexplained editorial rank.
Ask about a relationship
If a disclosure is unclear or appears missing, tell us which page and link concerned you. Use Contact and corrections or email partners@peptidecareindex.com. Our editorial standards explain the wider principles for evidence and accountability.